US Submission of Exforge(R) Accepted for Review By the FDA as a New Therapy Option for High Blood Pressure (Market Wire via Yahoo! Finance)
Novartis announced today that the new drug application for Exforge was accepted for standard review by the US Food and Drug Administration as a new treatment option for people with high blood pressure.

Parenteral packaging concerns for biotech drugs (Pharmalicencing)
Biotechnology promises treatments and even cures for many diseases previously considered intractable. Although the biotech industry began just about a quarter-century ago, since the late 1990s the number of new biopharmaceutical approvals has nearly equaled those for new small-molecule drugs.